Aprea Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.94

+0.06 (+6.93%)

As of May 16, 2:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +3,732.1% upside

Low Target $23.45

Average Target $36.06

High Target $38.88

Current Price $0.94

Current
$0.94

Target
$36.06

$23.45 $36.06 avg $38.88

Scenario Analysis

Bear Case

$23.45

2,392.0%

Low target

Base Case

$36.06

+3,732.1%

Avg target

Bull Case

$38.88

+4,031.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.22

-57.6% from high

52-Week Low

$0.55

+71.7% from low

Target vs 52W High

$36.06

+1,524.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%